Suchergebnisse - "Li, Yilin"

PubPharm (7)

1

Genome-wide quantification of copy-number aberration impact on gene expression in ovarian high-grade serous carcinoma

enthalten in: BMC cancer | 2024

von Jamalzadeh, S. | Dai, J. | Lavikka, K. | +10

2

Genome-wide quantification of copy-number aberration impact on gene expression in ovarian high-grade serous carcinoma

enthalten in: BMC cancer | 2024

von Jamalzadeh, S. | Dai, J. | Lavikka, K. | +10

3

Evolutionary states and trajectories characterized by distinct pathways stratify patients with ovarian high grade serous carcinoma

enthalten in: Cancer cell | 2023

von Lahtinen, A. | Lavikka, K. | Virtanen, A. | +19

CommentIn: Cancer Cell. 2023 Jun 12;41(6):1008-1010. - PMID 37311411

4

FOXD3 confers chemo-sensitivity in ovarian cancer through a miR-335/DAAM1/myosin II axis-dependent mechanism

enthalten in: Journal of ovarian research | 2023

von Wang, S. | Ma, Y. | Hu, Y. | +4

5

FOXD3 confers chemo-sensitivity in ovarian cancer through a miR-335/DAAM1/myosin II axis-dependent mechanism

enthalten in: Journal of ovarian research | 2023

von Wang, S. | Ma, Y. | Hu, Y. | +4

6

Comparison of the survival outcomes of laparoscopy versus laparotomy in treatment of early-stage ovarian cancer : a systematic review and meta-analysis

enthalten in: Journal of ovarian research | 2021

von Kong, Q. | Wei, H. | Zhang, J. | +2

7

Comparison of the survival outcomes of laparoscopy versus laparotomy in treatment of early-stage ovarian cancer: a systematic review and meta-analysis

enthalten in: Journal of ovarian research | 2021

von Kong, Q. | Wei, H. | Zhang, J. | +2

1
[1]